Disodium glycyrrhizinate can be taken before or after meals, and there is no evidence that glycyrrhizic acid causes significant gastric mucosal irritation and damage. Disodium glycyrrhizinate is a kind of hepatoprotective drug, which is suitable for the treatment of acute and chronic viral hepatitis accompanied by elevated alanine aminotransferase. Disodium glycyrrhizinate has anti-inflammatory, hepatoprotective and hepatic function-improving effects, reducing hepatocyte degeneration, necrosis and inflammatory cell infiltration. Common adverse effects of disodium glycyrrhizinate include nausea, nausea, vomiting, abdominal distension, pruritus, urticaria, dry mouth, and edema. In elderly patients, disodium glycyrrhizinate should be administered with caution, with the risk of causing hypokalemia, and the potential for fever, rash, hypertension, and edema. The medication should be used under the guidance of a medical professional, and should not be administered on its own.